# Dose Finding Confirmation of Atazanavir With Ritonavir and Efavirenz (ATV/RTV + EFV) in Healthy Subjects

> **NCT00357188** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 22 (—)

## Conditions studied

- HIV Infections
- Protease Inhibitor

## Interventions

- **DRUG:** Atazanavir Sulphate + Ritonavir
- **DRUG:** Atazanavir Sulphate + Ritonavir + Efavirenz

## Key facts

- **NCT ID:** NCT00357188
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2006-09
- **Final completion:** 2006-09
- **Target enrollment:** 22 (—)
- **Last updated:** 2011-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00357188

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00357188, "Dose Finding Confirmation of Atazanavir With Ritonavir and Efavirenz (ATV/RTV + EFV) in Healthy Subjects". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00357188. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*